methylglucamine metrizoate has been researched along with Liver Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asztely, M; Lukes, P; Tidebrant, G; Tylén, U | 1 |
| Lukes, P; Tidebrant, G; Tylén, U | 1 |
1 trial(s) available for methylglucamine metrizoate and Liver Neoplasms
| Article | Year |
|---|---|
Comparison of non-enhanced, bolus enhanced, and delayed scanning techniques in computed tomography of hepatic tumours.
Topics: Adult; Aged; Aged, 80 and over; Female; Humans; Liver Neoplasms; Male; Metrizoic Acid; Middle Aged; Prospective Studies; Time Factors; Tomography, X-Ray Computed | 1990 |
1 other study(ies) available for methylglucamine metrizoate and Liver Neoplasms
| Article | Year |
|---|---|
Contrast enhancement of liver parenchyma and biliary tract related to liver function at delayed computed tomography.
Topics: Biliary Tract; Contrast Media; Female; Humans; Liver; Liver Function Tests; Liver Neoplasms; Male; Metrizoic Acid; Middle Aged; Time Factors; Tomography, X-Ray Computed | 1990 |